** Shares of Cyclopharm up 17.2% at A$2.38
** Stock rises as much as 23.2% to A$2.5 in early trade, hitting its highest level since Oct 16, 2023
** Radiopharmaceutical firm signs contract with healthcare provider Hospital Corporation of America Healthcare $(HCA)$
** Says contract for deployment of co's Technegas imaging technology in up to 169 nuclear medicine departments across HCA'S network
** Co did not provide any transactional details regarding contract
** Technegas imaging technology is used to detect pulmonary embolism
** More than 502,000 shares change hands, 5.8 times the 30-day avg
** Cyclopahrm up 49.5% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。